Prescribing Information is available below. Adverse Event reporting can be found in the footer.
STADA Bone Health Hub
The STADA Bone Health Hub contains information and bone health resources that aim to support Healthcare Professionals in preventing fractures and preserving NHS resources.
Prevent Fractures, Preserve Resources
Every minute, someone in the UK suffers a fragility fracture.1 With osteoporotic fracture costs already £4.7 billion each year, the burden on the NHS is set to increase markedly as the population ages.1,2
For patients too, the consequences can be devastating. Hip and vertebral fractures tend to have the most worrying repercussions, but fractures at any site can impact on survival.3,4
Since there is no clinical specialty dedicated solely to bone health, sharing essential knowledge and tools to support the provision of optimal care for patients assumes particular importance.
That’s where our STADA Bone Health Hub fits in. As well as providing you with information on our four treatments spanning the bone health patient pathway, you will find clinical and patient guides to aid decision-making around treatments.
While age is a significant risk factor for developing osteoporosis, poor bone health later in life is not inevitable5
Consequently, our portfolio of cost-effective bone health treatments spans the patient pathway from prevention and management of vitamin D deficiency through to treatment of osteoporosis and fracture prevention.
Our portfolio offers prevention, treatment and management across the bone health patient pathway
Prevent & treat vitamin D deficiency6-8
Prevent & treat vitamin D and calcium deficiency9,10
Treat osteoporosis in women after menopause11
Treatment of osteoporosis in post-menopausal women and in men at increased risk of fracture12
The portfolio in detail:
Fultium-D3
Colecalciferol
The UK’s #1 prescribed licensed vitamin D brand, offering a range of loading and maintainance doses to suit flexible daily, weekly or monthly dosing6-8,13
Accrete®-D3
Calcium / Colecalciferol
The most cost-effective calcium + vitamin D brand offering a choice of chewable One a Day and swallowable twice daily tablets14
Binosto®
Alendronic acid
Buffered, effervescent alendronate formulation supporting adherence11,15,16
Movymia® ▼
Teriparatide
An affordable teriparatide biosimilar treatment, minimising waste with a reusable, multi-dose pen12,14
Let’s stay connected
Want to be the first to hear about the products, services and educational resources we offer, including invitations to webinars and events? Sign up to our mailing list for regular updates!
References
1. International Osteoporosis Foundation. Accessed: April 2026. 2. Odén A et al. Osteoporos Int 2015; 26(9): 2243-8. 3. Migliorini F et al. Medicina (Kaunas) 2021;57(10):1119. 4. Brown JP et al. BMC Musculoskelet Disord 2021; 22(1): 105. 5. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Osteoporosis. Accessed: April 2026. 6. Fultium-D3 800IU capsules Capsules SmPC. 7. Fultium-D3 3,200IU capsules Capsules SmPC. 8. Fultium-D3 20,000IU capsules Capsules SmPC. 9. Accrete®-D3 Film-Coated Tablets SmPC. 10. Accrete®-D3 One a Day 1000 mg/880 IU Chewable Tablets SmPC. 11. Binosto® SmPC. 12. Movymia® SmPC. 13. IQVIA. RXA Sales Dashboard – March 2026. Data on File, STADA UK, Thornton & Ross. 14. NHS DM+D. Accessed: April 2026. 15. Minisola S et al. JBMR Plus 2021; 5(7): e10510. 16. Giusti A et al. Aging Clin Exp Res 2021; 33(9): 2529-37.